BSE filing, NSE: DHANUKA. Summary written from the filing by ALFA Finder's alert engine.
Dhanuka Agritech Ltd: key numbers
- Share price
- ₹929.05
- Market cap
- ₹4,188 Cr
- Revenue (annual)
- ₹2,020 Cr
- Net profit (annual)
- ₹287.2 Cr
- P/E (TTM)
- 14.8×Sector 34.8×
- Promoter holding
- 69.81%+0.00% QoQ
- FII holding
- 1.59%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhanuka Agritech Ltd
All →Dhanuka Agritech Earnings Call Transcript: Key Takeaways
Dhanuka delivered resilient 9.91% revenue growth despite a 13% monsoon deficit, driven by a strong insecticide performance in North India.
- Call
- Guides 9% growth
Dhanuka Agritech Results Update
Dhanuka Agritech released a press release on its unaudited Q2 FY27 results, reporting profit and revenue growth. The release accompanies the results filing made under Regulation 30.
Dhanuka Agritech Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 657.51 Cr (+9.9% YoY), EBITDA Rs 152.97 Cr (+11.9%), PAT Rs 109.22 Cr (+16.2%). Margins expanded YoY despite a weak monsoon-hit sector.
Dhanuka Agritech Q2 FY27 Results: Net Profit ₹109.2 Cr, Up 16.2% YoY
Dhanuka Agritech Ltd reported revenue from operations of ₹657.5 Cr (+9.9% YoY) and net profit of ₹109.2 Cr (+16.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹109.2 Cr · +16.2% YoY
Dhanuka Agritech Board Meeting Date
Dhanuka Agritech Ltd notified exchanges of a board meeting on 30 October 2026 to consider Q2 and half-year unaudited financial results. The notice is a future meeting intimation with no decision yet taken.
Dhanuka Agritech Management Change
Dhanuka Agritech Limited announced the resignation of Umesh Verma, General Manager-Procurement, effective October 15, 2026. The departure is to pursue other career opportunities.
Other employee stock options announcements
All →Sai Life Science Employee Stock Options
Sai Life Sciences allotted 108,005 ESOP equity shares, taking paid-up capital to Rs.21.26 Crore. No stated consideration means no event value.
Billionbrains Garage Ventures Employee Stock Options
Billionbrains Garage Ventures granted 21,63,086 stock options to eligible employees under its 2024 ESOP scheme. Each option carries an exercise price of Rs. 2 per share.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Zensar Technologies Employee Stock Options
Zensar Technologies allotted 31,440 equity shares to employees on exercise of ESOPs. Paid-up share capital rose to ₹45.55 crore across 22.78 crore shares.
IIFL Finance Employee Stock Options
IIFL Finance allotted 1,97,523 equity shares to eligible employees on exercise of ESOPs, approved by the NRC on 5 November 2026. No cash consideration per share is stated in the filing.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.